Latanoprost / Timolol Farmalider

Latanoprost and Timolol Maleate, the active ingredients in Latanoprost / Timolol Farmalider, are a prostaglandin analog and beta‑blocker combination presented as eye drops for ocular use. They lower intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension.

GNH USA supplies Latanoprost / Timolol Farmalider as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost / Timolol is a combination ophthalmic therapy that targets intra‑ocular pressure regulation in glaucoma‑related conditions.

Open‑angle glaucoma: reduces intra‑ocular pressure to prevent optic nerve damage. Ocular hypertension: lowers elevated eye pressure to reduce risk of progression to glaucoma. Secondary glaucoma (when indicated): provides additive pressure‑lowering effect alongside other treatments.

Adverse reactions may occur with ocular use of the combination.

Common Side Effects: - Eye irritation or burning sensation - Transient blurred vision - Conjunctival hyperemia (red eye) - Dry eye or foreign‑body sensation - Increased eyelash growth - Mild itching or discomfort

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angio‑edema, anaphylaxis) - Sudden loss of vision or acute ocular pain - Worsening of glaucoma due to hypotony - Systemic bronchospasm or asthma exacerbation - Bradycardia or heart block in susceptible patients - Chest pain or signs of myocardial ischemia

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and follow safe handling guidelines.

Assess cardiovascular status: avoid in patients with severe asthma, COPD, bradycardia or heart block. Monitor intra‑ocular pressure: schedule regular ophthalmic examinations. Check beta‑blocker contraindications: review concomitant systemic beta‑blocker use. Avoid concurrent prostaglandin analogs: prevent excessive pressure reduction. Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. Store at room temperature: keep bottle in original packaging, protect from light and moisture.

Latanoprost / Timolol may interact with other systemic or ocular agents; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid): - Non‑selective systemic beta‑blockers: additive bradycardia and hypotension. - Other ocular prostaglandin analogues: risk of excessive intra‑ocular pressure lowering (hypotony). - Systemic carbonic anhydrase inhibitors: may potentiate hypotensive effects. - Sympathomimetic agents (e.g., epinephrine eye drops): can diminish timolol efficacy.

Moderate Interactions (Monitor Closely): - Topical ocular anesthetics: may increase ocular irritation. - Systemic antihypertensives: monitor blood pressure for additive lowering. - Corticosteroid eye drops: possible reduction in pressure‑lowering effect. - Anticholinergic eye preparations: watch for compounded ocular side effects.